US Bancorp’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.3K | Buy |
6,212
+687
| +12% | +$6.33K | ﹤0.01% | 2707 |
|
|
2025
Q1 | $47.4K | Sell |
5,525
-147
| -3% | -$1.26K | ﹤0.01% | 2766 |
|
|
2024
Q4 | $60.9K | Buy |
5,672
+29
| +0.5% | +$311 | ﹤0.01% | 2650 |
|
|
2024
Q3 | $32.1K | Buy |
5,643
+479
| +9% | +$2.72K | ﹤0.01% | 2941 |
|
|
2024
Q2 | $21.8K | Sell |
5,164
-311
| -6% | -$1.31K | ﹤0.01% | 3028 |
|
|
2024
Q1 | $27.9K | Buy |
5,475
+52
| +1% | +$265 | ﹤0.01% | 2951 |
|
|
2023
Q4 | $50.5K | Buy |
5,423
+259
| +5% | +$2.41K | ﹤0.01% | 2669 |
|
|
2023
Q3 | $33.8K | Buy |
5,164
+4,907
| +1,909% | +$32.1K | ﹤0.01% | 2625 |
|
|
2023
Q2 | $2.09K | Sell |
257
-607
| -70% | -$4.93K | ﹤0.01% | 3645 |
|
|
2023
Q1 | $7.4K | Buy |
864
+658
| +319% | +$5.64K | ﹤0.01% | 3377 |
|
|
2022
Q4 | $1.91K | Buy |
206
+42
| +26% | +$389 | ﹤0.01% | 3768 |
|
|
2022
Q3 | $2K | Hold |
164
| – | – | ﹤0.01% | 3776 |
|
|
2022
Q2 | $2K | Buy |
+164
| New | +$2K | ﹤0.01% | 3770 |
|
|
2022
Q1 | – | Sell |
-505
| Closed | -$9K | – | 4026 |
|
|
2021
Q4 | $9K | Buy |
505
+478
| +1,770% | +$8.52K | ﹤0.01% | 3425 |
|
|
2021
Q3 | $0 | Buy |
+27
| New | – | ﹤0.01% | 4026 |
|